» Articles » PMID: 20571116

Composition, Variability, and Temporal Stability of the Intestinal Microbiota of the Elderly

Abstract

Alterations in the human intestinal microbiota are linked to conditions including inflammatory bowel disease, irritable bowel syndrome, and obesity. The microbiota also undergoes substantial changes at the extremes of life, in infants and older people, the ramifications of which are still being explored. We applied pyrosequencing of over 40,000 16S rRNA gene V4 region amplicons per subject to characterize the fecal microbiota in 161 subjects aged 65 y and older and 9 younger control subjects. The microbiota of each individual subject constituted a unique profile that was separable from all others. In 68% of the individuals, the microbiota was dominated by phylum Bacteroides, with an average proportion of 57% across all 161 baseline samples. Phylum Firmicutes had an average proportion of 40%. The proportions of some phyla and genera associated with disease or health also varied dramatically, including Proteobacteria, Actinobacteria, and Faecalibacteria. The core microbiota of elderly subjects was distinct from that previously established for younger adults, with a greater proportion of Bacteroides spp. and distinct abundance patterns of Clostridium groups. Analyses of 26 fecal microbiota datasets from 3-month follow-up samples indicated that in 85% of the subjects, the microbiota composition was more like the corresponding time-0 sample than any other dataset. We conclude that the fecal microbiota of the elderly shows temporal stability over limited time in the majority of subjects but is characterized by unusual phylum proportions and extreme variability.

Citing Articles

Bi-Directional Relationship Between Bile Acids (BAs) and Gut Microbiota (GM): UDCA/TUDCA, Probiotics, and Dietary Interventions in Elderly People.

Francini E, Badillo Pazmay G, Fumarola S, Procopio A, Olivieri F, Marchegiani F Int J Mol Sci. 2025; 26(4).

PMID: 40004221 PMC: 11855466. DOI: 10.3390/ijms26041759.


Association of prebiotic/probiotic intake with MASLD: evidence from NHANES and randomized controlled trials in the context of prediction, prevention, and a personalized medicine framework.

Wang S, Zhang R, Guo P, Yang H, Liu Y, Zhu H EPMA J. 2025; 16(1):183-197.

PMID: 39991098 PMC: 11842653. DOI: 10.1007/s13167-025-00398-4.


Benefits of equilibrium between microbiota- and host-derived ligands of the aryl hydrocarbon receptor after stroke in aged male mice.

Peesh P, Blasco-Conesa M, El Hamamy A, Khan R, Guzman G, Honarpisheh P Nat Commun. 2025; 16(1):1767.

PMID: 39971928 PMC: 11839985. DOI: 10.1038/s41467-025-57014-2.


MAIT cell homing in intestinal homeostasis and inflammation.

Wu Z, Chen X, Han F, Leeansyah E Sci Adv. 2025; 11(6):eadu4172.

PMID: 39919191 PMC: 11804934. DOI: 10.1126/sciadv.adu4172.


Decoding the chicken gastrointestinal microbiome.

Burrows P, Godoy-Santos F, Lawther K, Richmond A, Corcionivoschi N, Huws S BMC Microbiol. 2025; 25(1):35.

PMID: 39833701 PMC: 11744950. DOI: 10.1186/s12866-024-03690-x.


References
1.
Raes J, Foerstner K, Bork P . Get the most out of your metagenome: computational analysis of environmental sequence data. Curr Opin Microbiol. 2007; 10(5):490-8. DOI: 10.1016/j.mib.2007.09.001. View

2.
Schwiertz A, Taras D, Schafer K, Beijer S, Bos N, Donus C . Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2009; 18(1):190-5. DOI: 10.1038/oby.2009.167. View

3.
Kotlowski R, Bernstein C, Sepehri S, Krause D . High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2006; 56(5):669-75. PMC: 1942160. DOI: 10.1136/gut.2006.099796. View

4.
Andersson A, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L . Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One. 2008; 3(7):e2836. PMC: 2475661. DOI: 10.1371/journal.pone.0002836. View

5.
Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L . Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2005; 55(2):205-11. PMC: 1856500. DOI: 10.1136/gut.2005.073817. View